Zobrazeno 1 - 9
of 9
pro vyhledávání: '"David Aggen"'
Autor:
Jason Luke, Meredith McKean, Nehal Lakhani, Katherine Kacena, Alan Tan, Babar Bashir, David Aggen, Marissa Timothy, Sergio Santillana
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/05aab1271bb545dca1191f26e39af1ca
Autor:
Samuel A. Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Aggen, Danielle Zimmerman, Deaglan McHugh, Arlyn Apollo, Trey D. Durdin, Hong Truong, Jeffrey Kamradt, Maged Khalil, Bradley Lash, Irina Ostrovnaya, Asia S. McCoy, Grace Hettich, Ashley Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W. Herr, S. Machele Donat, Eugene Pietzak, Eugene K. Cha, Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun V. Balar, Amir Mortazavi, Jonathan E. Rosenberg
Publikováno v:
J Clin Oncol
PURPOSE Neoadjuvant gemcitabine and cisplatin (GC) followed by radical cystectomy (RC) is standard for patients with muscle-invasive bladder cancer (MIBC). On the basis of the activity of atezolizumab (A) in metastatic BC, we tested neoadjuvant GC pl
Autor:
Ali Mouzannar, Karissa Whiting, Irina Ostrovnaya, Andrew Katims, Trey Durdin, Zachary Feuer, Michael Lattanzi, Hikmat Al-Ahmadie, Colleen Quinlan, Min Teo, David Aggen, Hong Truong, Jeffrey Kamradt, Maged Khalil, Bradley Lash, Ashley Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Yuanquan Yang, Kamal Pohar, Harry Herr, Sherri Donat, Eugene Pietzak, Eugene Cha, Timothy Donahue, William Huang, Dean Bajorin, Gopakumar Iyer, Bernard Bochner, Amir Mortazavi, Arjun Balar, Jonathan Rosenberg, Samuel Funt, Alvin Goh
Publikováno v:
Journal of Urology. 209
Autor:
David Aggen, Meredith McKean, Nehal Lakhani, Babar Bashir, Jean Hoffman-Censits, Omar Alhalabi, Elizabeth Guancial, Isaac Bowman, Alan Tan, Trupti Lingaraj, Marissa Timothy, Nerymar Ortiz-Otero, Wilmin Bartolini, Katherine Kacena, Karim Malek, Sergio Santillana, Jason Luke
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Maura Gillison, Jiaxin Niu, Daniel Olson, Mark Stein, David Aggen, Utkarsh Acharya, Benjamin Creelan, Richard Hernandez, Jessica Price, Kevin J. Mancini, Louisa Dowal, James Foti, Vijetha Vemulapalli, Mara Shainheit, Masoud Golshadi, Raymond D. Stapleton, Jessica B. Flechtner, Thomas A. Davis
Publikováno v:
Cancer Research. 82:CT153-CT153
TiTAN™ is an open-label, multi-center Phase1/2a trial evaluating safety, tolerability, T-cell persistence and proliferation, and clinical activity in patients with some solid tumors. Adoptive T-cell therapies (ACT) have resulted in durable clinical
Autor:
Nivedita Chowdhury, Aleksandar Obradovic, David Aggen, Vinson Wang, Xinzheng Guo, Guarionex J. DeCastro, Hongxu Ding, Andrea Califano, Charles G. Drake
Publikováno v:
Cancer Research. 79:1476-1476
Immune cells in the tumor microenvironment (TME) play a critical role in regulating tumor development and response to targeted immunotherapy. While it is well-accepted that clear cell renal carcinoma (ccRCC) is characterized by a T-cell infiltrate, d
Autor:
Lawrence G. Lum, Abhinav Deol, Divaya Bhutani, Kendra Mellert, Joseph P. Uberti, David Aggen, Lois Ayash, Voravit Ratanatharathorn
Publikováno v:
Blood. 126:3228-3228
An inherent difficulty in performing allogeneic transplantation in patients (pts) of African American (AA) descent is finding suitably matched 8/8 unrelated donors. In addition for complicated reasons studies have shown that AA have an inferior survi
Autor:
Roman Barraza, Sarwan Kumar, Shahniwaz Labana, Cesar Hidalgo, Ahmad Ghabsha, Meena Azeem, David Aggen
Publikováno v:
Chest. 148:241A
Publikováno v:
Chest. 146:179A